BBR Partners’s Centessa Pharmaceuticals CNTA Stock Holding History

BBR Partners’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,551	Closed	-$260K	–	256
2026 Q1	$260K	Buy	+6,551	New	+$168K	0.01%	218

BBR Partners's CNTA Position: Q2 2026 in Review

BBR Partners sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 6,551 shares — an estimated $260K sold.

BBR Partners first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $260K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

BBR Partners reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
BBR Partners sold 6,551 Centessa Pharmaceuticals shares in Q2 2026, an estimated $260K.
BBR Partners first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
BBR Partners's Centessa Pharmaceuticals position peaked at $260K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on BBR Partners's 13F filing for Q2 2026, filed 11 Aug 2026.